Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer

Journal of Thoracic and Cardiovascular Surgery

Volumn 127, Issue 6, 2004, Pages 1579-1586

  Kulke, Matthew H ^a   Odze, Robert D ^b   Mueller, James D ^b   Wang, Helen ^c   Redston, Mark ^b   Bertagnolli, Monica M ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOOXYGENASE 2; FLUOROURACIL; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BEAM THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STROMA CELL; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR BIOPSY; TUMOR CELL;

EID: 2642570227     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2003.12.034     Document Type: Article

References (29)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin. 2002;52:23-47.
2. Heath E, Burtness B, Heitmiller R, et al. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant therapy for squamous cell and adenocarcinoma of the esophagus. J Clin Oncol. 2000;18:868-76.
3. Forastiere A, Heitmiller R, Lee D, et al. Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus. Cancer J Sci Am. 1997;3:144-52.
4. Leung D, Cachianes G, Kuang W, Goeddel D, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246:1306-9.
5. Thomas K. Vascular endothelial growth factor, a potent and selective angiogenic agent, J Biol Chem. 1996;271:603-6.
6. Shih C, Ozawa S, Ando N, Ueda M, Kitajima M. Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus. Clin Cancer Res. 2000;6:1161-8.
7. Kitadai Y, Haruma K, Tokutomi T, et al. Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas. Clin Cancer Res. 1998;4:2195-200.
8. Inoue K, Ozeki Y, Suganuma T, Sugiura Y, Tanaka S. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Cancer. 1997;79:206-13.
9. Uchida S, Shimada Y, Watanabe G, et al. In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage, and poor prognosis. Br J Cancer. 1998;77:1704-9.
10. Sato F, Shimada Y, Watanabe G, Uchida S, Makino T, Imamura M. Expression of vascular endothelial growth factor, matrix metalloproteinase-9, and E-cadherin in the process of lymph node metastasis in oesophageal cancer. Br J Cancer. 1999;80:1366-72.
11. Shimada H, Hoshino T, Okazumi S, et al. Expression of angiogenic factors predicts response to chemoradiotherapy and prognosis of oesophageal squamous cell carcinoma. Br J Cancer. 2002;86:552-7.
12. Imdahl A, Bognar G, Schulte-Montig J, Schoffel U, Farthmann E, Ihling C. Predictive factors for response to neoadjuvant therapy in patients with oesophageal cancer. Eur J Cardiothorac Surg. 2002;21:657-63.
13. Hironaka S, Hasabe T, Kamijo T, et al. Biopsy specimen microvessel density is a useful prognostic marker in patients with T2-4M0 esophageal cancer treated with chemoradiotherapy. Clin Cancer Res. 2002;8:124-30.
14. Torres C, Wang H, Turner J, Shahsafaei A, Odze R. Prognostic significance and effect of chemoradiotherapy on microvessel density (angiogenesis) in esophageal Barrett's esophagus-associated adenocarcinoma and squamous cell carcinoma. Hum Pathol. 1999;30:753-8.
15. Masferrer J, Leahy K, Koki A, et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res. 2000;60:1306-11.
16. Leahy K, Ornberg R, Wang Y, Zweifel B, Koki A, Masferrer J. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res. 2002;62:625-31.
17. Shi H, Xu J, Hu N, Xie H. Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma. World J Gastroenterol. 2003;9:1421-6.
18. Denkert C, Winzer K, Muller B, et al. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma. Cancer. 2003;97:2978-87.
19. Kim S, Kwon S, Kim Y, Hong S. Association of cyclooxygenase-2 expression with prognosis of stage T1 grade 3 bladder cancer. Urology. 2002;60:816-21.
20. Ferrandia G, Lauriola L, Distefano M, et al. Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients. J Clin Oncol. 2002;20:973-81.
21. Gallo O, Masini E, Bianchi B, Bruschini L, Paglierani M, Franchi A. Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma. Hum Pathol. 2002;33:708-14.
22. Ferrandina G, Laurioloa L, Zannoni G, et al. Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients. Ann Oncol. 2002;13:1205-11.
23. Kim Y, Kim G, Cho N, et al. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy. Cancer. 2002;95:531-9.
24. Buskens C, VanRees B, Sivula A, et al. Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus. Gastroenterology. 2002;122:1800-7.
25. Khan K, Masferrer J, Woerner B, Soslow R, Koki A. Enhanced cyclooxygenase-2 expression in sporadic and familial adenomatous polyposis of the human colon. Scand J Gastroenterol. 2001;36:865-9.
26. Remmele W, Stegner H, Vorschlag zur einheitlichen Definition eines Immunreativen Score (IRS) fur den immunohistochemischen Ostrogenrezeptor-Nachweis (ER-ICA) im Mammakarzinomgewebe. Pathologe. 1987;8:138-40.
27. Gelb A, Sudilovsky D, Wu C, Weiss L, Medeiros L. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma. Cancer. 1997;80:1768-75.
28. Griffin R, Williams B, Wild R, Cherrington J, Park H, Song C. Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances radiation response. Cancer Res. 2002;62:1702-6.
29. Gorski D, Beckett M, Jaskowiak N, et al. Blockade of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res. 1999;59:3374-8.